Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 15 | Atay OguzhanDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $180K 1,961 sh | Oct 14, 2026 |
| 15 | Franks Joshua AllenSVP, Operations | Open-market sale · 10b5-1 plan | SELL | $920K 8,366 sh | Oct 14, 2026 traded Oct 12, 2026 |
| 15 | Craig Carol MarleneDirector | Grant or award | A | — 200.0K sh | Oct 14, 2026 traded Oct 9, 2026 |
| 15 | O'Hare RobertChief Financial Officer | Option exercise · 10b5-1 plan | M | $325K 5,636 sh | Oct 14, 2026 traded Oct 9, 2026 |
| 15 | Gordon Susan M.Director | Option exercise | M | — 85 sh | Oct 14, 2026 traded Oct 11, 2026 |
| 15 | Plunkett Debora ADirector | Option exercise | M | — 85 sh | Oct 14, 2026 traded Oct 11, 2026 |
| 15 | Myers Robert PaulChief Medical Officer | Grant or award | A | — 40.0K sh | Oct 14, 2026 traded Oct 9, 2026 |
| 15 | Bys Jay A.EVP & Chief Commercial Officer | Open-market sale · 10b5-1 plan | SELL | $643K 11.9K sh | Oct 14, 2026 traded Oct 12, 2026 |
| 15 | Plunkett Debora ADirector | Option exercise | M | — 85 sh | Oct 14, 2026 traded Oct 11, 2026 |
| 15 | Lawrence Paul JamesSVP & Chief Financial Officer | Tax withholding | F | $347K 5,433 sh | Oct 14, 2026 traded Oct 12, 2026 |
| 15 | Martinez Merla JaimeChief Comptroller | Tax withholding | F | $429K 35.3K sh | Oct 14, 2026 traded Oct 14, 2026 |
| 15 | McCarthy Ryan DDirector | Option exercise | M | — 85 sh | Oct 14, 2026 traded Oct 11, 2026 |
| 15 | Disbrow Lisa SDirector | Option exercise | M | — 123 sh | Oct 14, 2026 traded Oct 11, 2026 |
| 15 | Disbrow Lisa SDirector | Option exercise | M | — 123 sh | Oct 14, 2026 traded Oct 11, 2026 |
| 15 | Myers Robert PaulChief Medical Officer | Grant or award | A | — 25.0K sh | Oct 14, 2026 traded Oct 9, 2026 |
| 15 | Gordon Susan M.Director | Option exercise | M | — 85 sh | Oct 14, 2026 traded Oct 11, 2026 |
| 15 | Atay OguzhanDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $238K 2,553 sh | Oct 14, 2026 traded Oct 12, 2026 |
| 15 | Burwig Susan EExec. VP, Operations | Option exercise | M | $500K 3,000 sh | Oct 14, 2026 traded Oct 12, 2026 |
| 15 | McCarthy Ryan DDirector | Option exercise | M | — 85 sh | Oct 14, 2026 traded Oct 11, 2026 |
| 14 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $489K 2,499 sh | Oct 14, 2026 traded Oct 13, 2026 |
| 14 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $523K 2,700 sh | Oct 14, 2026 traded Oct 13, 2026 |
| 14 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $275K 1,401 sh | Oct 14, 2026 traded Oct 13, 2026 |
| 14 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $765K 3,790 sh | Oct 14, 2026 traded Oct 12, 2026 |
| 14 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $271K 1,444 sh | Oct 14, 2026 traded Oct 13, 2026 |
| 14 | Conine StevenDirector | Open-market sale · 10b5-1 plan | SELL | $64K 594 sh | Oct 14, 2026 traded Oct 12, 2026 |
| 14 | Shah NirajDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $64K 594 sh | Oct 14, 2026 traded Oct 12, 2026 |
| 14 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $643K 3,241 sh | Oct 14, 2026 traded Oct 13, 2026 |
| 14 | Atay OguzhanDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $260K 2,667 sh | Oct 14, 2026 traded Oct 12, 2026 |
| 14 | Hall John TDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $120K 3,000 sh | Oct 14, 2026 traded Oct 12, 2026 |
| 14 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $295K 1,550 sh | Oct 14, 2026 traded Oct 13, 2026 |
| 14 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $596K 3,150 sh | Oct 14, 2026 traded Oct 13, 2026 |
| 14 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $564K 2,999 sh | Oct 14, 2026 traded Oct 13, 2026 |
| 14 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $271K 1,456 sh | Oct 14, 2026 traded Oct 13, 2026 |
| 14 | Jampol ThadChief Product Officer | Open-market sale · 10b5-1 plan | SELL | $194K 4,800 sh | Oct 14, 2026 traded Oct 13, 2026 |
| 14 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $665K 3,360 sh | Oct 14, 2026 traded Oct 13, 2026 |
| 14 | Klamkin JonathanDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $1.05M 100.0K sh | Oct 14, 2026 traded Oct 12, 2026 |
| 13 | McEvoy William Patrick IIIDirector, Chief Investment Officer, 10% Owner | In-the-money exercise | X | $4,939 4.94M sh | Oct 14, 2026 traded Oct 12, 2026 |
| 13 | Hosein ClydeDirector | Grant or award | A | — 1,222 sh | Oct 14, 2026 traded Oct 13, 2026 |
| 13 | Absher Jody KSVP, Chief Legal Officer & Sec | Grant or award | A | — 8,348 sh | Oct 14, 2026 traded Oct 12, 2026 |
| 13 | Lawrence Paul JamesSVP & Chief Financial Officer | Grant or award | A | — 13.8K sh | Oct 14, 2026 traded Oct 12, 2026 |